Daratumumab (Darzalex) Injection from China
Daratumumab targets CD38 for multiple myeloma. HTS 3002.15.00.11 immunological monoclonal.
Duty Rate — China → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Hematology-specific FDA paths